Laine V J, Grass D S, Nevalainen T J
Department of Pathology, University of Turku, Turku University Hospital, Finland.
J Immunol. 1999 Jun 15;162(12):7402-8.
Group II phospholipase A2 (PLA2) is an enzyme that has marked antibacterial properties in vitro. To define the role of group II PLA2 in the defense against Staphylococcus aureus, we studied host responses in transgenic mice expressing human group II PLA2 and group II PLA2-deficient C57BL/6J mice in experimental S. aureus infection. After the administration of S. aureus, the transgenic mice showed increased expression of group II PLA2 mRNA in the liver and increased concentration of group II PLA2 in serum, whereas the PLA2-deficient mice completely lacked the PLA2 response. Expression of human group II PLA2 resulted in reduced mortality and improved the resistance of the mice by killing the bacteria as indicated by low numbers of live bacteria in their tissues. Human group II PLA2 was responsible for the bactericidal activity of transgenic mouse serum. These results suggest a possible role for group II PLA2 in the innate immunity against S. aureus infection.
II 型磷脂酶 A2(PLA2)是一种在体外具有显著抗菌特性的酶。为了确定 II 型 PLA2 在抵御金黄色葡萄球菌中的作用,我们在实验性金黄色葡萄球菌感染中研究了表达人 II 型 PLA2 的转基因小鼠和 II 型 PLA2 缺陷型 C57BL/6J 小鼠的宿主反应。给予金黄色葡萄球菌后,转基因小鼠肝脏中 II 型 PLA2 mRNA 的表达增加,血清中 II 型 PLA2 的浓度升高,而 PLA2 缺陷型小鼠则完全没有 PLA2 反应。人 II 型 PLA2 的表达降低了死亡率,并通过杀死细菌提高了小鼠的抵抗力,其组织中活菌数量较少表明了这一点。人 II 型 PLA2 负责转基因小鼠血清的杀菌活性。这些结果表明 II 型 PLA2 在针对金黄色葡萄球菌感染的先天免疫中可能发挥作用。